4.4 |
21.8 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
4.3 |
12.8 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
3.9 |
15.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
2.5 |
12.3 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
2.4 |
9.8 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
2.3 |
9.1 |
GO:0009414 |
response to water deprivation(GO:0009414) |
2.2 |
6.7 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
2.2 |
13.1 |
GO:0032796 |
uropod organization(GO:0032796) |
2.2 |
15.2 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
2.2 |
12.9 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
2.0 |
6.1 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
2.0 |
6.1 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
2.0 |
8.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.9 |
13.0 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
1.7 |
3.5 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
1.7 |
8.6 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
1.6 |
4.9 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.6 |
4.9 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.6 |
8.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
1.6 |
4.8 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.5 |
7.6 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
1.5 |
7.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
1.5 |
14.8 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
1.5 |
4.4 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
1.5 |
10.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.5 |
8.8 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.4 |
5.8 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
1.4 |
4.2 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
1.4 |
4.1 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
1.3 |
5.4 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
1.2 |
6.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
1.2 |
6.1 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.2 |
4.8 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
1.2 |
3.5 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
1.1 |
26.4 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
1.1 |
6.8 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
1.1 |
4.5 |
GO:0042938 |
dipeptide transport(GO:0042938) |
1.1 |
4.4 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) |
1.1 |
3.2 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
1.1 |
3.2 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.1 |
4.3 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.0 |
14.6 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
1.0 |
7.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.0 |
18.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.0 |
3.1 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
1.0 |
4.1 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
1.0 |
3.9 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
1.0 |
8.8 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
1.0 |
2.9 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
1.0 |
4.9 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
1.0 |
3.9 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
1.0 |
3.8 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
0.9 |
6.5 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.9 |
3.7 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 |
7.1 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.9 |
4.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
0.9 |
3.5 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
0.9 |
2.6 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.9 |
2.6 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
0.8 |
3.3 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
0.8 |
4.9 |
GO:0060539 |
diaphragm development(GO:0060539) |
0.8 |
3.2 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
0.8 |
1.6 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
0.8 |
2.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
0.7 |
1.5 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
0.7 |
3.6 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
0.7 |
2.1 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
0.7 |
2.8 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.7 |
2.8 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.7 |
2.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.7 |
6.8 |
GO:0007379 |
segment specification(GO:0007379) |
0.7 |
6.5 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
0.6 |
1.9 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
0.6 |
4.5 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
0.6 |
2.5 |
GO:0046958 |
nonassociative learning(GO:0046958) |
0.6 |
3.7 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
0.6 |
10.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.6 |
3.6 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glycolytic process through glucose-1-phosphate(GO:0061622) glucose catabolic process to pyruvate(GO:0061718) |
0.6 |
3.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
0.6 |
7.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
0.6 |
5.8 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.6 |
2.9 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.6 |
2.9 |
GO:0030242 |
pexophagy(GO:0030242) |
0.6 |
5.1 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.5 |
3.3 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 |
4.3 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.5 |
10.7 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.5 |
3.2 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
0.5 |
1.6 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
0.5 |
5.3 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 |
2.6 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
0.5 |
2.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.5 |
1.5 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
0.5 |
2.0 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
0.5 |
1.9 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
0.5 |
7.2 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.5 |
1.4 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.5 |
3.3 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
0.5 |
2.3 |
GO:2000650 |
negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.5 |
1.8 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 |
3.2 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
0.5 |
3.6 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
0.5 |
3.6 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 |
10.8 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.4 |
1.3 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
0.4 |
3.4 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
0.4 |
1.7 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
0.4 |
2.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 |
7.6 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
0.4 |
1.7 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.4 |
2.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
0.4 |
0.4 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 |
1.6 |
GO:0030501 |
positive regulation of bone mineralization(GO:0030501) |
0.4 |
2.8 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.4 |
2.4 |
GO:0032329 |
serine transport(GO:0032329) |
0.4 |
4.3 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
0.4 |
7.8 |
GO:0014047 |
glutamate secretion(GO:0014047) |
0.4 |
1.9 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) maintenance of centrosome location(GO:0051661) regulation of microtubule motor activity(GO:2000574) |
0.4 |
6.9 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
0.4 |
3.4 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
0.4 |
1.8 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
0.4 |
2.6 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 |
0.7 |
GO:1900426 |
positive regulation of defense response to bacterium(GO:1900426) |
0.4 |
1.5 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 |
1.5 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
0.4 |
10.2 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.4 |
5.4 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
0.4 |
0.7 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.4 |
4.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
0.4 |
2.5 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 |
1.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 |
2.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
0.3 |
1.0 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 |
5.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
0.3 |
0.7 |
GO:1900424 |
regulation of defense response to bacterium(GO:1900424) |
0.3 |
1.0 |
GO:0016056 |
photoreceptor cell morphogenesis(GO:0008594) rhodopsin mediated signaling pathway(GO:0016056) post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 |
11.0 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 |
6.7 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 |
1.3 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
0.3 |
1.3 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.3 |
14.3 |
GO:0008542 |
visual learning(GO:0008542) |
0.3 |
4.9 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 |
1.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
0.3 |
1.0 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
0.3 |
7.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
0.3 |
0.6 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.3 |
0.9 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 |
1.6 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
0.3 |
7.8 |
GO:0010043 |
response to zinc ion(GO:0010043) |
0.3 |
5.3 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
0.3 |
0.9 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
0.3 |
0.9 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
0.3 |
3.6 |
GO:0051601 |
exocyst localization(GO:0051601) |
0.3 |
1.8 |
GO:1903056 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) melanocyte migration(GO:0097324) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
0.3 |
1.7 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
0.3 |
1.4 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 |
1.2 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 |
0.6 |
GO:1902287 |
semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 |
1.4 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 |
2.2 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
0.3 |
1.9 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
0.3 |
2.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
0.3 |
2.9 |
GO:0035999 |
methionine biosynthetic process(GO:0009086) tetrahydrofolate interconversion(GO:0035999) |
0.3 |
1.6 |
GO:1903423 |
positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 |
1.6 |
GO:0003383 |
apical constriction(GO:0003383) |
0.3 |
1.0 |
GO:0019042 |
viral latency(GO:0019042) |
0.3 |
0.5 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
0.3 |
0.8 |
GO:0051031 |
tRNA transport(GO:0051031) |
0.3 |
0.8 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 |
0.8 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 |
3.0 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 |
3.0 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 |
6.7 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 |
16.7 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 |
1.9 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
0.2 |
0.7 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 |
0.7 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 |
14.9 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 |
1.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.2 |
3.0 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
0.2 |
1.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 |
2.5 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
0.2 |
4.8 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
0.2 |
1.4 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
0.2 |
1.5 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
0.2 |
1.1 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
0.2 |
2.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
0.2 |
1.1 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
0.2 |
3.9 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 |
0.4 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 |
6.4 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
0.2 |
3.0 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
0.2 |
1.0 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 |
2.3 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
0.2 |
14.0 |
GO:0007612 |
learning(GO:0007612) |
0.2 |
1.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
0.2 |
5.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 |
1.4 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
0.2 |
2.2 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
0.2 |
1.4 |
GO:0043084 |
penile erection(GO:0043084) |
0.2 |
2.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 |
0.4 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 |
1.4 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 |
2.5 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
0.2 |
2.7 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
0.2 |
0.6 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.2 |
1.9 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 |
0.4 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 |
0.6 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
0.2 |
3.3 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 |
0.9 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 |
1.4 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
0.2 |
7.0 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
0.2 |
3.8 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
0.2 |
5.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
0.2 |
2.7 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 |
1.0 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
0.2 |
1.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
0.2 |
1.0 |
GO:0046036 |
GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.2 |
0.5 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
0.2 |
4.3 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 |
1.3 |
GO:0007602 |
phototransduction(GO:0007602) |
0.2 |
1.5 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
0.2 |
7.2 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 |
4.2 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
0.2 |
0.9 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
0.2 |
0.9 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 |
1.4 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 |
4.5 |
GO:0032456 |
endocytic recycling(GO:0032456) |
0.2 |
3.6 |
GO:0010107 |
potassium ion import(GO:0010107) |
0.1 |
4.3 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
0.1 |
0.7 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 |
0.3 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 |
0.6 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 |
1.0 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 |
2.6 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
0.1 |
0.4 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 |
1.1 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 |
1.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 |
3.7 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 |
0.8 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
0.1 |
0.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
0.1 |
0.7 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 |
2.7 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
0.1 |
4.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
0.1 |
4.6 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 |
0.5 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 |
9.1 |
GO:0007416 |
synapse assembly(GO:0007416) |
0.1 |
2.4 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 |
11.8 |
GO:0006342 |
chromatin silencing(GO:0006342) |
0.1 |
0.5 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 |
0.5 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
0.1 |
0.9 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
0.1 |
2.2 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 |
13.4 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
0.1 |
1.3 |
GO:0002920 |
regulation of humoral immune response(GO:0002920) |
0.1 |
1.5 |
GO:0045453 |
bone resorption(GO:0045453) |
0.1 |
1.1 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 |
2.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
0.1 |
1.2 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
0.1 |
0.6 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
0.1 |
0.4 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 |
2.8 |
GO:0031114 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 |
0.4 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
0.1 |
2.9 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
0.1 |
0.8 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
0.1 |
1.8 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 |
1.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
0.1 |
0.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
0.1 |
0.6 |
GO:0045214 |
sarcomere organization(GO:0045214) |
0.1 |
1.3 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
0.1 |
1.7 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
0.1 |
1.0 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
0.1 |
5.7 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
0.1 |
2.6 |
GO:0007520 |
myoblast fusion(GO:0007520) |
0.1 |
1.8 |
GO:0006301 |
postreplication repair(GO:0006301) |
0.1 |
4.7 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
0.1 |
1.0 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
0.1 |
0.4 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
0.1 |
0.6 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
0.1 |
2.9 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
0.1 |
0.7 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
0.1 |
3.8 |
GO:0048278 |
vesicle docking(GO:0048278) |
0.1 |
1.8 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
0.1 |
3.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
0.1 |
0.3 |
GO:0030070 |
insulin processing(GO:0030070) |
0.1 |
3.7 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 |
0.6 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
0.1 |
2.9 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
0.1 |
2.9 |
GO:0006584 |
catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.1 |
0.8 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
0.1 |
3.5 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
0.1 |
1.0 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
0.1 |
1.4 |
GO:0034389 |
lipid particle organization(GO:0034389) |
0.1 |
0.9 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
0.1 |
1.0 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
0.1 |
1.8 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
0.1 |
3.1 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 |
1.3 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 |
0.3 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
0.1 |
1.2 |
GO:0015914 |
phospholipid transport(GO:0015914) |
0.1 |
0.4 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
0.1 |
0.8 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 |
2.0 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 |
0.6 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 |
1.1 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 |
1.1 |
GO:0018210 |
peptidyl-threonine modification(GO:0018210) |
0.1 |
0.7 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
0.1 |
0.3 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 |
0.7 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
0.1 |
1.8 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 |
2.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
0.1 |
0.5 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
0.1 |
0.1 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
0.1 |
0.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
0.1 |
0.9 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
0.1 |
0.1 |
GO:0061724 |
lipophagy(GO:0061724) |
0.1 |
0.6 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 |
0.5 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
0.1 |
0.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
0.1 |
0.5 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 |
6.3 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
0.1 |
0.5 |
GO:0070242 |
thymocyte apoptotic process(GO:0070242) |
0.1 |
0.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
0.1 |
5.5 |
GO:0006497 |
protein lipidation(GO:0006497) |
0.1 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 |
5.1 |
GO:0048515 |
spermatid differentiation(GO:0048515) |
0.1 |
1.7 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
0.1 |
0.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
0.1 |
0.6 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
0.1 |
1.4 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 |
0.5 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
0.1 |
0.3 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 |
2.0 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
0.1 |
0.2 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
0.1 |
3.3 |
GO:0030705 |
cytoskeleton-dependent intracellular transport(GO:0030705) |
0.1 |
0.2 |
GO:1900040 |
regulation of interleukin-2 secretion(GO:1900040) positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 |
0.5 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
0.1 |
0.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
0.1 |
2.0 |
GO:0010332 |
response to gamma radiation(GO:0010332) |
0.1 |
0.7 |
GO:0019228 |
neuronal action potential(GO:0019228) |
0.1 |
1.0 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 |
0.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
0.0 |
0.5 |
GO:0048286 |
lung alveolus development(GO:0048286) |
0.0 |
0.6 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 |
1.1 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 |
0.4 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
0.0 |
1.2 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
0.0 |
0.3 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 |
0.6 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 |
2.7 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 |
2.0 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
0.0 |
0.1 |
GO:1903861 |
dendrite extension(GO:0097484) regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 |
4.2 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 |
0.3 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 |
0.5 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
0.0 |
1.4 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
0.0 |
0.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 |
0.2 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 |
0.2 |
GO:0001659 |
temperature homeostasis(GO:0001659) |
0.0 |
1.2 |
GO:0051298 |
centrosome duplication(GO:0051298) |
0.0 |
0.8 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 |
0.1 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
0.0 |
1.5 |
GO:0030518 |
intracellular steroid hormone receptor signaling pathway(GO:0030518) |
0.0 |
0.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
0.0 |
0.2 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
0.0 |
0.3 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
0.0 |
1.0 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 |
0.8 |
GO:0051297 |
centrosome organization(GO:0051297) |
0.0 |
0.2 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
0.0 |
0.4 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
0.0 |
0.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
0.0 |
1.2 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 |
0.2 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 |
1.7 |
GO:0050890 |
cognition(GO:0050890) |
0.0 |
0.1 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
0.0 |
0.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 |
0.6 |
GO:0006284 |
base-excision repair(GO:0006284) |
0.0 |
0.3 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
0.0 |
0.1 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 |
0.5 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 |
0.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
0.0 |
0.1 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
0.0 |
0.8 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
0.0 |
0.3 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
0.0 |
0.7 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
0.0 |
0.7 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 |
0.3 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
0.0 |
0.3 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |